Get started
AVICANNA INCAVICANNA INCAVICANNA INC

AVICANNA INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

AVCN chart


Full chart

AVCN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪35.82 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.065 CAD
Net income (FY)
‪−7.89 M‬ CAD
Revenue (FY)
‪16.79 M‬ CAD
Shares float
‪83.61 M‬
Beta (1Y)
1.14

Employees


Employees (FY)
97
Change (1Y)
+7 +7.78%
Revenue / Employee (1Y)
‪173.11 K‬ CAD
Net income / Employee (1Y)
‪−81.29 K‬ CAD

About AVICANNA INC


Sector
Health Technology
Industry
Biotechnology
CEO
Aras Azadian
Website
avicanna.com
Headquarters
Toronto
Founded
2015
FIGI
BBG00NLM6LN9
Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. It operates through the following two segments: Research and Development and Cultivation. The Research and Development segment conducts business in Johnson & Johnson Innovation centre. The Cultivation segment controls two companies located in Santa Marta, Colombia that are authorized to cultivate and process cannabis for the production of Extracts, including Cannabidiol and Tetrahydrocannabinol. The company was founded by Aras Azadian, Kyle Langstaff, and Setu Purohit in May 2015 and is headquartered in Toronto, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AVCN news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AVCN is 0.325 CAD — it has decreased by −4.41% in the past 24 hours. Watch AVICANNA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange AVICANNA INC stocks are traded under the ticker AVCN.
AVCN stock has fallen by −8.45% compared to the previous week, the month change is a 38.30% rise, over the last year AVICANNA INC has showed a −18.75% decrease.
AVCN reached its all-time high on Jul 18, 2019 with the price of 7.400 CAD, and its all-time low was 0.160 CAD and was reached on Jun 16, 2022. View more price dynamics on AVCN chart.
See other stocks reaching their highest and lowest prices.
AVCN stock is 4.62% volatile and has beta coefficient of 1.14. Track AVICANNA INC stock price on the chart and check out the list of the most volatile stocks — is AVICANNA INC there?
Today AVICANNA INC has the market capitalization of ‪35.82 M‬, it has decreased by −8.57% over the last week.
Yes, you can track AVICANNA INC financials in yearly and quarterly reports right on TradingView.
AVICANNA INC is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
AVCN net income for the last quarter is ‪−876.22 K‬ CAD, while the quarter before that showed ‪−1.76 M‬ CAD of net income which accounts for 50.20% change. Track more AVICANNA INC financial stats to get the full picture.
No, AVCN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 97.00 employees. See our rating of the largest employees — is AVICANNA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AVICANNA INC EBITDA is ‪−4.41 M‬ CAD, and current EBITDA margin is −41.10%. See more stats in AVICANNA INC financial statements.
Like other stocks, AVCN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AVICANNA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AVICANNA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AVICANNA INC stock shows the sell signal. See more of AVICANNA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.